China Jo-Jo Drugstores Operating Income

As of the most recent data (May 2026), CJJD shows a operating income of $-8.2M. That compares with $-29M in the prior-year period — up 71.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CJJD's operating income is now $-8.2M (was $-29M) — a 71.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether China Jo-Jo Drugstores is outperforming or lagging.

Tracking CJJD's operating income over time shows whether China Jo-Jo Drugstores is scaling, shrinking, or reshaping that part of the business. The current reading is $-8.2M That compares with $-29M in the prior-year period — up 71.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has China Jo-Jo Drugstores's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-8.2M) with ownership activity and broader fundamentals.

China Jo-Jo Drugstores's operating income is $-8.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.